Screener
Nuvation Bio NUVB Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Short-term borrowings | 5,893 | 5,724 |
| Warrant liability | — | 2,865 |
| Accrued expenses | 45,204 | 45,183 |
| Total current liabilities | 86,755 | 82,231 |
| Contract liabilities, net of current portion | 8,228 | 11,305 |
| Non-current operating lease liabilities | 1,910 | 2,543 |
| Non-current liability related to revenue interest financing agreement, net of deferred financing costs of $3,818 and $4,241, respectively | 151,122 | 145,819 |
| Long-term borrowings, net of deferred financing costs of $3,042 | — | 47,208 |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's total current liabilities?
- Nuvation Bio (NUVB) reported total current liabilities of $86.76M in Q2 2026.
- How has Nuvation Bio's total current liabilities changed year-over-year?
- Nuvation Bio's total current liabilities increased by 30.7% year-over-year, from $66.36M to $86.76M.
- What is the long-term trend for Nuvation Bio's total current liabilities?
- Over 5 years (2020 to 2025), Nuvation Bio's total current liabilities has grown at a 65.9% compound annual growth rate (CAGR), from $6.55M to $82.23M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Nuvation Bio's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude